
|Articles|March 1, 2004
Betamethasone valerate effective for short-term stasis dermatitis
Waikoloa, Hawaii -- Pilot study results indicate that 0.12 percent betamethasone valerate foam is more effective than vehicle alone for short-term stasis dermatitis treatment. "This topical therapy can lead to improved health-related quality of life in these patients," said Alexa Boer Kimball, M.D., assistant professor and director, dermatology clinical trials, Stanford University School of Medicine.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Hilary Baldwin, MD, Highlights Emerging Acne and Rosacea Therapies at Elevate-Derm
2
Advancing Topical Stewardship and Expanding Nonsteroidal Options
3
Triamcinolone Shows Transcriptomic Shifts in AD Within 24 Hours
4
Douglas DiRuggiero, PA-C, DMSc, Recognized at the Elevate-Derm Fall Conference
5



















